Vitamin D3 supplementation and treatment outcomes in patients with depression (D3-vit-dep).
Jens Peter HansenManan PareekAllan HvolbyAnne SchmedesTomas ToftErik DahlConnie Thurøe NielsenPublished in: BMC research notes (2019)
At baseline, 23 patients had a normal 25(OH)D level, 22 had insufficiency (< 25 nmol/L), and 17 had deficiency (25-50 nmol/L). No significant reduction in depression was seen after vitamin D supplementation compared to placebo at Hamilton (18.4-18.0; p = 0.73 at 12 weeks). Vitamin D supplementation did not provide a reduction in symptom score among patients with depression. Trial registration The trial was registered in the National Board of Health (EudraCT: 2011-002585-20) and in ClinicalTrials.Gov (NCT01390662).
Keyphrases
- depressive symptoms
- phase iii
- end stage renal disease
- sleep quality
- study protocol
- clinical trial
- healthcare
- newly diagnosed
- public health
- chronic kidney disease
- ejection fraction
- phase ii
- mental health
- peritoneal dialysis
- open label
- patient reported
- risk assessment
- double blind
- climate change
- social media
- health information
- gestational age
- human health